6 line items for prazosin HCL capsules. Awarded for a base year of 2/19/2023 to 2/18/2024 with four one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79722D0038
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Prazosin HCL Capsules Pre-Solicitation · 36E79722R0034 · Posted Aug 16, 2022
- Last date to order 93% complete
- IDV ceiling
- $28,781,200.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for Prazosin HCL capsules with a ceiling of $28.78 million on February 19, 2023. The contract carries no set-aside designation.
Work is performed at Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary performance locations in Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and other designated federal delivery locations as specified by contracting agencies.
The originating solicitation (RFP 36E79722R0034) sought unrestricted procurement of six presentations of Prazosin HCL capsules for supply to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Annual requirements ranged from 5,518 to 80,000 bottles across the six presentations, totaling approximately 103,500 bottles annually.
The contract runs from February 19, 2023 through February 18, 2024 (base year) with four one-year option periods extending to ultimate completion on February 18, 2027. The procurement incorporated Section 5 of Executive Order 14398 regarding diversity, equity, and inclusion requirements. NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals) apply.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Show all 15
Quick answers
Who was awarded contract 36E79722D0038?
36E79722D0038 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on February 19, 2023.
How much is contract 36E79722D0038 worth?
36E79722D0038's own ceiling is $28,781,200.
Who can order from contract 36E79722D0038?
36E79722D0038 is a single award indefinite delivery contract.
Was contract 36E79722D0038 competed?
The extent of competition for 36E79722D0038 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV